Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Canonical and Non Canonical Activation of Hedgehog Pathway in Multiple Myeloma

Simona Blotta, Klaus Podar, Yu-Tzu Tai, Aldo M. Roccaro, Gullu Gorgun, Brunella Franco, Constantine S. Mitsiades, Salvatore Venuta, Kenneth C. Anderson

Blood (2008) 112 (11): 2748.

https://doi.org/10.1182/blood.V112.11.2748.2748

Published: 2008

Journal Articles

Novel Murine Model To Study Modulation of Genes and Molecular Pathways Induced Following In Vivo Interaction between Multiple Myeloma Cells and Human BM Milieu.

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood Shammas, PhD, Mariateresa Fulciniti, PhD, Yu-Tzu Tai, PhD, Simona Blotta, MD, Rao Prabhala, PhD, Mariateresa Di Martino, PhD, Laurence Catley, MD, Pierosandro Tagliaferri, MD, Salvatore Venuta, MD, Ruben Carrasco, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 3409.

https://doi.org/10.1182/blood.V108.11.3409.3409

Published: 2006

Journal Articles

Defining a Murine Model To Study Bone Disease in Multiple Myeloma (MM).

Paola Neri, MD, Pierfrancesco Tassone, MD, Zhenxin Shen, PhD, Nipun Patel, PhD, Robert Fajardo, PhD, Mariateresa Fulciniti, PhD, Rao Prabhala, PhD, Masood Shammas, PhD, Simona Blotta, MD, Teru Hideshima, MD, Dharminder Chauhan, PhD, John Muller, PhD, Salvatore Venuta, MD, Brian D. Snyder, MD, Steven R. Goldring, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 3518.

https://doi.org/10.1182/blood.V108.11.3518.3518

Published: 2006

Journal Articles

Biological Pathways and In Vivo Anti-Tumor Activity Induced by Atiprimod in Multiple Myeloma (MM).

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood Shammas, PhD, Hiroshi Yasui, MD, Ernestina Schipani, MD, Ramesh B. Batchu, PhD, Simona Blotta, MD, Rao Prabhala, PhD, Laurence Catley, MD, Makoto Hamasaki, MD, Teru Hideshima, MD, Dharminder Chauhan, PhD, Gary S. Jacob, PhD, Donald Picker, PhD, Salvatore Venuta, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 3455.

https://doi.org/10.1182/blood.V108.11.3455.3455

Published: 2006

Journal Articles

The In Vivo Activity of Neutralizing B Cell-Activating Factor (BAFF) Antibody in the Treatment of Multiple Myeloma (MM).

Paola Neri, MD, Shaji Kumar, MD, Mariateresa Fulciniti, MD, Sonia Vallet, MD, Shweta Chhetri, Hiroshi Yasui, Yu-Tzu Tai, PhD, Dharminder Chauhan, Teru Hideshima, Pierfrancesco Tassone, Salvatore Venuta, Nikhil C. Munshi, Kenneth C. Anderson, Noopur Raje

Blood (2006) 108 (11): 843.

https://doi.org/10.1182/blood.V108.11.843.843

Published: 2006

Journal Articles

Identification of Novel Antigens with Induced Immune Response in MGUS.

Simona Blotta, MD, Hiroshi Yasui, MD, Pierfrancesco Tassone, MD, Roberto Bellucci, PhD, Yu-Tzu Tai, PhD, Rao Prabhala, PhD, Masood A. Shammas, PhD, Pierosandro Tagliaferri, MD, Klaus Podar, MD, PhD, Paola E. Neri, MD, Mariateresa Fulciniti, PhD, Vidit Munshi, Dharminder Chauhan, PhD, Teru Hideshima, MD, PhD, Salvatore Venuta, MD, PhD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 655.

https://doi.org/10.1182/blood.V108.11.655.655

Published: 2006

Journal Articles

BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B

Alessandra Aloisi, Sandra Di Gregorio, Fabio Stagno, Patrizia Guglielmo, Francesca Mannino, Maria Pia Sormani, Paolo Bruzzi, Carlo Gambacorti-Passerini, Giuseppe Saglio, Salvatore Venuta, Rosario Giustolisi, Angelo Messina, Paolo Vigneri

Blood (2006) 107 (4): 1591–1598.

https://doi.org/10.1182/blood-2005-05-2123

Published: 2006

Includes: Supplemental data

Journal Articles

Identification of Target Antigens Recognized in MGUS for Immunotherapeutic Approaches.

Simona Blotta, MD, Roberto Bellucci, PhD, Pierfrancesco Tassone, MD, Rao Prabhala, PhD, Paola Neri, MD, Masood Shammas, PhD, Ramesh R. Batchu, PhD, Jooeun E. Bae, PhD, Cheng Li, PhD, Salvatore Venuta, MD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 3463.

https://doi.org/10.1182/blood.V106.11.3463.3463

Published: 2005

Journal Articles

In Vivo Anti-Tumor Activity of Atiprimod on SCID Models of Multiple Myeloma.

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood A. Shammas, PhD, Ramesh B. Batchu, PhD, Simona Blotta, MD, Sushma Samala, PhD, Laurence Catley, MD, Makoto Hamasaki, PhD, Teru Hideshima, MD, Gary S. Jacob, PhD, Donald H. Picker, PhD, Salvatore Venuta, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 249.

https://doi.org/10.1182/blood.V106.11.249.249

Published: 2005

Journal Articles

Novel Model To Evaluate Changes in Gene Expression Profile of Myeloma Cells In Vivo Following Interaction with Human BM Microenvironment.

Paola Neri, MD, Pierfrancesco Tassone, MD, Masood A. Shammas, PhD, Daniel R. Carrasco, MD, Renate Burger, PhD, Constantine S. Mitsdiades, MD, Simona Blotta, MD, Rao H. Prabhala, PhD, Laurence Catley, MD, Salvatore Venuta, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 2490.

https://doi.org/10.1182/blood.V106.11.2490.2490

Published: 2005

Journal Articles

A SCID-hu in vivo model of human Waldenström macroglobulinemia

Pierfrancesco Tassone, Paola Neri, Jeffery L. Kutok, Olivier Tournilhac, Daniel Ditzel Santos, Evdoxia Hatjiharissi, Vidit Munshi, Salvatore Venuta, Kenneth C. Anderson, Steven P. Treon, Nikhil C. Munshi

Blood (2005) 106 (4): 1341–1345.

https://doi.org/10.1182/blood-2004-11-4477

Published: 2005

Journal Articles

Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells

Raffaella Avellino, Simona Romano, Rosanna Parasole, Rita Bisogni, Annalisa Lamberti, Vincenzo Poggi, Salvatore Venuta, Maria Fiammetta Romano

Blood (2005) 106 (4): 1400–1406.

https://doi.org/10.1182/blood-2005-03-0929

Published: 2005

Journal Articles

A clinically relevant SCID-hu in vivo model of human multiple myeloma

Pierfrancesco Tassone, Paola Neri, Daniel R. Carrasco, Renate Burger, Victor S. Goldmacher, Robert Fram, Vidit Munshi, Masood A. Shammas, Laurence Catley, Gary S. Jacob, Salvatore Venuta, Kenneth C. Anderson, Nikhil C. Munshi

Blood (2005) 106 (2): 713–716.

https://doi.org/10.1182/blood-2005-01-0373

Published: 2005

Journal Articles

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

Ennio Carbone, Paola Neri, Maria Mesuraca, Mariateresa T. Fulciniti, Takemi Otsuki, Daniela Pende, Veronika Groh, Thomas Spies, Giuditta Pollio, David Cosman, Lucio Catalano, Pierfrancesco Tassone, Bruno Rotoli, Salvatore Venuta

Blood (2005) 105 (1): 251–258.

https://doi.org/10.1182/blood-2004-04-1422

Published: 2005

Journal Articles

Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138 + multiple myeloma cells

Pierfrancesco Tassone, Victor S. Goldmacher, Paola Neri, Antonella Gozzini, Masood A. Shammas, Kathleen R. Whiteman, Linda L. Hylander-Gans, Daniel R. Carrasco, Teru Hideshima, Reshma Shringarpure, Jialan Shi, Charles K. Allam, John Wijdenes, Salvatore Venuta, Nikhil C. Munshi, Kenneth C. Anderson

Blood (2004) 104 (12): 3688–3696.

https://doi.org/10.1182/blood-2004-03-0963

Published: 2004

Journal Articles

A Clinically Relevant SCID-hu in Vivo Model of Human Multiple Myeloma.

Pierfrancesco Tassone, MD, Paola Neri, MD, Daniel R. Carrasco, MD, Renate Burger, PhD, Laurence Catley, MD, Salvatore Venuta, MD, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 2455.

https://doi.org/10.1182/blood.V104.11.2455.2455

Published: 2004

Journal Articles

A Novel Murine Model for Human Waldenstrom’s Macroglobulinemia.

Pierfrancesco Tassone, MD, Paola Neri, MD, Jeffery Kutok, MD, Olivier Tournilhac, MD, Daniel Ditzel Santos, MD, Evdoxia Hatjiharissi, MD, Salvatore Venuta, MD, PhD, Kenneth C. Anderson, MD, Steven Treon, MD, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 3646.

https://doi.org/10.1182/blood.V104.11.3646.3646

Published: 2004

Journal Articles

Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells

Heather M. Bond, Maria Mesuraca, Ennio Carbone, Patrizia Bonelli, Valter Agosti, Nicola Amodio, Gennaro De Rosa, Massimo Di Nicola, Alessandro M. Gianni, Malcolm A. S. Moore, Akiko Hata, Michele Grieco, Giovanni Morrone, Salvatore Venuta

Blood (2004) 103 (6): 2062–2070.

https://doi.org/10.1182/blood-2003-07-2388

Published: 2004

Journal Articles

Amifostine Inhibits Hematopoietic Progenitor Cell Apoptosis by Activating NF-κB/Rel Transcription Factors

Maria Fiammetta Romano, Annalisa Lamberti, Rita Bisogni, Corrado Garbi, Antonio M. Pagnano, Pasquale Auletta, Pierfrancesco Tassone, Maria Caterina Turco, Salvatore Venuta

Blood (1999) 94 (12): 4060–4066.

https://doi.org/10.1182/blood.V94.12.4060

Published: 1999

Journal Articles

Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells

Maria Fiammetta Romano, Annalisa Lamberti, Pierfrancesco Tassone, Fiorella Alfinito, Silvia Costantini, Federico Chiurazzi, Thierry Defrance, Patrizio Bonelli, Franca Tuccillo, Maria Caterina Turco, Salvatore Venuta

Blood (1998) 92 (3): 990–995.

https://doi.org/10.1182/blood.V92.3.990

Published: 1998

NARROW

Canonical and Non Canonical Activation of Hedgehog Pathway in Multiple Myeloma

Novel Murine Model To Study Modulation of Genes and Molecular Pathways Induced Following In Vivo Interaction between Multiple Myeloma Cells and Human BM Milieu.

Defining a Murine Model To Study Bone Disease in Multiple Myeloma (MM).

Biological Pathways and In Vivo Anti-Tumor Activity Induced by Atiprimod in Multiple Myeloma (MM).

The In Vivo Activity of Neutralizing B Cell-Activating Factor (BAFF) Antibody in the Treatment of Multiple Myeloma (MM).

Identification of Novel Antigens with Induced Immune Response in MGUS.

BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B

Identification of Target Antigens Recognized in MGUS for Immunotherapeutic Approaches.

In Vivo Anti-Tumor Activity of Atiprimod on SCID Models of Multiple Myeloma.

Novel Model To Evaluate Changes in Gene Expression Profile of Myeloma Cells In Vivo Following Interaction with Human BM Microenvironment.

A SCID-hu in vivo model of human Waldenström macroglobulinemia

Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells

A clinically relevant SCID-hu in vivo model of human multiple myeloma

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138 + multiple myeloma cells

A Clinically Relevant SCID-hu in Vivo Model of Human Multiple Myeloma.

A Novel Murine Model for Human Waldenstrom’s Macroglobulinemia.

Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells

Amifostine Inhibits Hematopoietic Progenitor Cell Apoptosis by Activating NF-κB/Rel Transcription Factors

Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only